247 related articles for article (PubMed ID: 33610717)
1. Biased agonism at adenosine receptors.
McNeill SM; Baltos JA; White PJ; May LT
Cell Signal; 2021 Jun; 82():109954. PubMed ID: 33610717
[TBL] [Abstract][Full Text] [Related]
2. New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism.
Vecchio EA; Baltos JA; Nguyen ATN; Christopoulos A; White PJ; May LT
Br J Pharmacol; 2018 Nov; 175(21):4036-4046. PubMed ID: 29679502
[TBL] [Abstract][Full Text] [Related]
3. Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases.
Geldenhuys WJ; Hanif A; Yun J; Nayeem MA
Molecules; 2017 Jun; 22(6):. PubMed ID: 28587166
[TBL] [Abstract][Full Text] [Related]
4. Keep an eye on adenosine: Its role in retinal inflammation.
Santiago AR; Madeira MH; Boia R; Aires ID; Rodrigues-Neves AC; Santos PF; Ambrósio AF
Pharmacol Ther; 2020 Jun; 210():107513. PubMed ID: 32109489
[TBL] [Abstract][Full Text] [Related]
5. Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases.
Gaudry M; Vairo D; Marlinge M; Gaubert M; Guiol C; Mottola G; Gariboldi V; Deharo P; Sadrin S; Maixent JM; Fenouillet E; Ruf J; Guieu R; Paganelli F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727116
[TBL] [Abstract][Full Text] [Related]
6. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
[TBL] [Abstract][Full Text] [Related]
7. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
Borah P; Deka S; Mailavaram RP; Deb PK
Curr Pharm Des; 2019; 25(26):2792-2807. PubMed ID: 31333097
[TBL] [Abstract][Full Text] [Related]
8. Biased agonism and allosteric modulation of metabotropic glutamate receptor 5.
Trinh PNH; May LT; Leach K; Gregory KJ
Clin Sci (Lond); 2018 Nov; 132(21):2323-2338. PubMed ID: 30389826
[TBL] [Abstract][Full Text] [Related]
9. Adenosine Receptor Reserve and Long-Term Potentiation: Unconventional Adaptive Mechanisms in Cardiovascular Diseases?
Guieu R; Brignole M; Deharo JC; Deharo P; Mottola G; Groppelli A; Paganelli F; Ruf J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299203
[TBL] [Abstract][Full Text] [Related]
10. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
[TBL] [Abstract][Full Text] [Related]
11. Quantification of adenosine A(1) receptor biased agonism: Implications for drug discovery.
Baltos JA; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
Biochem Pharmacol; 2016 Jan; 99():101-12. PubMed ID: 26581123
[TBL] [Abstract][Full Text] [Related]
12. Adenosinergic Pathway in Parkinson's Disease: Recent Advances and Therapeutic Perspective.
Zhao Y; Liu X; Yang G
Mol Neurobiol; 2023 Jun; 60(6):3054-3070. PubMed ID: 36786912
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modulators for adenosine receptors: an alternative to the orthosteric ligands.
La Motta C; Sartini S; Morelli M; Taliani S; Da Settimo F
Curr Top Med Chem; 2010; 10(10):976-92. PubMed ID: 20370657
[TBL] [Abstract][Full Text] [Related]
14. Adenosine receptors: Modulators of lipid availability that are controlled by lipid levels.
Leiva A; Guzmán-Gutiérrez E; Contreras-Duarte S; Fuenzalida B; Cantin C; Carvajal L; Salsoso R; Gutiérrez J; Pardo F; Sobrevia L
Mol Aspects Med; 2017 Jun; 55():26-44. PubMed ID: 28153452
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Insights Into Safety and Efficacy Determinants for the Development of Adenosine Receptor Biased Agonists in the Treatment of Heart Failure.
Rueda P; Merlin J; Chimenti S; Feletou M; Paysant J; White PJ; Christopoulos A; Sexton PM; Summers RJ; Charman WN; May LT; Langmead CJ
Front Pharmacol; 2021; 12():628060. PubMed ID: 33776771
[TBL] [Abstract][Full Text] [Related]
16. New paradigms in purinergic receptor ligand discovery.
Jacobson KA; Pradhan B; Wen Z; Pramanik A
Neuropharmacology; 2023 Jun; 230():109503. PubMed ID: 36921890
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of adenosine receptors.
Göblyös A; Ijzerman AP
Biochim Biophys Acta; 2011 May; 1808(5):1309-18. PubMed ID: 20599682
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of Adenosine Receptors: The State of the Art.
Borea PA; Gessi S; Merighi S; Vincenzi F; Varani K
Physiol Rev; 2018 Jul; 98(3):1591-1625. PubMed ID: 29848236
[TBL] [Abstract][Full Text] [Related]
19. Small molecule allosteric modulation of the adenosine A
Nguyen ATN; Tran QL; Baltos JA; McNeill SM; Nguyen DTN; May LT
Front Endocrinol (Lausanne); 2023; 14():1184360. PubMed ID: 37435481
[TBL] [Abstract][Full Text] [Related]
20. PET Imaging of Adenosine Receptors in Diseases.
Li J; Hong X; Li G; Conti PS; Zhang X; Chen K
Curr Top Med Chem; 2019; 19(16):1445-1463. PubMed ID: 31284861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
